HHMI
PVH icon

Howard Hughes Medical Institute’s PVH PVH Stock Holding History

Howard Hughes Medical Institute’s Portfolio PVH Stock Details PVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,720
Closed -$426K – 101
2017
Q2 		$426K Sell
3,720
-802
-18% -$83.2K 0.08% 99
2017
Q1 		$468K Buy
4,522
+872
+24% +$80.7K 0.09% 93
2016
Q4 		$329K Sell
3,650
-213
-6% -$22.4K 0.08% 111
2016
Q3 		$427K Buy
3,863
+96
+3% +$9.92K 0.11% 99
2016
Q2 		$355K Buy
+3,767
New +$354K 0.12% 101
2016
Q1 		– Sell
-40,399
Closed -$2.98M – 189
2015
Q4 		$2.98M Buy
40,399
+239
+0.6% +$21.1K 0.45% 35
2015
Q3 		$4.09M Sell
40,160
-5,398
-12% -$613K 0.77% 25
2015
Q2 		$5.25M Buy
45,558
+6,203
+16% +$673K 1.11% 21
2015
Q1 		$4.19M Buy
39,355
+21,590
+122% +$2.34M 0.57% 31
2014
Q4 		$2.28M Buy
17,765
+9,659
+119% +$1.16M 0.61% 45
2014
Q3 		$982K Buy
8,106
+4,135
+104% +$485K 0.22% 55
2014
Q2 		$463K Buy
+3,971
New +$494K 0.08% 60

Other funds holding PVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Howard Hughes Medical Institute's PVH Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of PVH (PVH) in Q3 2017, closing a stake of 3,720 shares — an estimated $426K sold.

Howard Hughes Medical Institute first reported a position in PVH in Q2 2014 and held it in 12 quarters. The position peaked at $5.25M in Q2 2015. 489 funds tracked by Wall St. Rank hold PVH as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining PVH position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 3,720 PVH shares in Q3 2017, an estimated $426K.
  • Howard Hughes Medical Institute first reported a position in PVH in Q2 2014 and held it in 12 quarters.
  • Howard Hughes Medical Institute's PVH position peaked at $5.25M in Q2 2015.
  • 489 funds tracked by Wall St. Rank held PVH as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.